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DivIVA proteins are curvature sensitive membrane binding proteins that recruit other proteins 2 
to the poles and the division septum. They consist of a conserved N-terminal lipid binding 3 
domain fused to a less conserved C-terminal domain. DivIVA homologues interact with 4 
different proteins involved in cell division, chromosome segregation, genetic competence, or 5 
cell wall synthesis. It is unknown how DivIVA interacts with these proteins, and we used the 6 
interaction of Bacillus subtilis DivIVA with MinJ and RacA to investigate this. MinJ is a 7 
trans-membrane protein controlling division site selection, and the DNA-binding protein 8 
RacA is crucial for chromosome segregation during sporulation. Initial bacterial two-hybrid 9 
experiments revealed that the C-terminus of DivIVA appears to be important for recruiting 10 
both proteins. However, the interpretation of these results is limited since it appeared that C-11 
terminal truncations also interfere with DivIVA oligomerization. Therefore a chimera 12 
approach was followed, making use of the fact that Listeria monocytogenes DivIVA shows 13 
normal polar localization but is not biologically active when expressed in B. subtilis. 14 
Complementation experiments with different chimeras of B. subtilis and L. monocytogenes 15 
DivIVA suggest that MinJ and RacA bind to separate DivIVA domains. Fluorescence 16 
microscopy of GFP-tagged RacA and MinJ corroborated this conclusion, and suggests that 17 
MinJ recruitment operates via the N-terminal lipid binding domain, whereas RacA interacts 18 
with the C-terminal domain. We speculate that this difference is related to the cellular 19 





DivIVA homologues constitute a group of highly conserved cell division proteins in Gram-2 
positive bacteria. They bind to the cytosolic face of the cytoplasmic membrane and 3 
accumulate at membrane regions with increased negative curvature in rod shaped bacteria (1-4 
3). Negatively curved (i.e. concave) membrane regions occur at the cell poles and along the 5 
cytokinetic ring as soon as it starts to constrict and invaginates the cell membrane. Membrane 6 
binding and curvature sensitivity appears to be an intrinsic feature of DivIVA as it was shown 7 
that DivIVA of Bacillus subtilis also localises to curved membranes when expressed in other, 8 
non-related species, including  yeast cells (4). DivIVA is used as scaffold and recruits other 9 
proteins that function in cell division, cell wall biosynthesis, secretion, genetic competence, or 10 
chromosome segregation (5-13). The proteins that interact with DivIVA are therefore diverse 11 
and comprise both trans-membrane and cytosolic proteins (14). The best characterised 12 
DivIVA protein is that of B. subtilis for which four different interaction partners are known: 13 
(i) the trans-membrane protein MinJ which acts as a molecular bridge between DivIVA and 14 
the FtsZ inhibiting MinCD complex (11, 12), (ii) the DNA-binding protein RacA that is 15 
required for chromosome segregation during spore formation (8, 15), (iii) the competence-16 
specific inhibitor of cell division Maf (16), and (iv) the competence regulator ComN (17). 17 
Nothing is known about the molecular interaction between DivIVA and its interaction 18 
partners. We set out to determine DivIVA interaction domains in more detail and focussed on 19 
the binding of B. subtilis DivIVA with MinJ and RacA.  20 
The crystal structure of B. subtilis DivIVA revealed a two-domain organisation; a 21 
highly conserved N-terminal domain that forms a dimeric structure with a characteristic cap 22 
structure and a less conserved C-terminal domain that is rich in coiled-coils but varies in 23 
length among the different bacterial species (18). These domains are connected by a flexible 24 
~20 amino acid linker (Fig. 1). The N-terminal domain is required for the lipid binding of 25 
DivIVA and for localization (1, 18, 19). The dimeric cap structure of this lipid binding 26 
 4
domain (LBD) exposes two phenylalanine side chains (F17, one per subunit), and the 1 
insertion of these side chains into the hydrophobic core of the phospholipid bilayer is essential 2 
for lipid binding (18). This membrane interaction is stabilized by auxiliary electrostatic 3 
interactions between positively charged arginine and lysine residues (R18 and K15) in the 4 
immediate vicinity of F17 and the negatively charged phospholipid head groups (18). The 5 
crystal structure suggested that the central coiled-coil region of the C-terminal domain 6 
contributes to DivIVA dimerization (Fig. 1B), and that the end of this domain (amino acids 7 
130-153) forms an antiparallel four-helix bundle constituting the tetramerization domain (TD) 8 
whereby two DivIVA dimers are linked together in an end-to-end orientation (18) (Fig. 1A-9 
B). The C-terminal part of DivIVA is the least conserved domain; it differs in length and can 10 
contain large insertions (Fig. 1A). It was therefore speculated that this domain is responsible 11 
for the interaction with other proteins (14).  12 
To test whether the C-terminus of DivIVA comprises the partner interaction domain, 13 
we tested C-terminally truncated variants of B. subtilis DivIVA for their interaction with MinJ 14 
and RacA using the bacterial two-hybrid system. These experiments proved inconclusive 15 
since removal of the tetramerization domain appeared to affect oligomerization. Therefore we 16 
set up a complementation assay with chimeric DivIVA proteins that consist of domains from 17 
B. subtilis and Listeria monocytogenes DivIVA. The latter protein localizes normally when 18 
expressed in B. subtilis but is biologically inactive and is unable to recruit MinJ or RacA to 19 
the cell division sites and cell poles. This experiment revealed that the sporulation activity and 20 
the cell division activity of DivIVA can be separated. It emerged that the trans-membrane 21 
protein MinJ binds to the N-terminal lipid binding domain of DivIVA, whereas the C-terminal 22 
domain of DivIVA contains the binding site for the cytosolic protein RacA.  23 
24 
 5
MATERIALS AND METHODS 1 
Bacterial strains and growth conditions 2 
All bacterial strains that were used in this study are listed in Table 1. Routinely, B. subtilis 3 
strains were cultivated in LB broth or on LB agar at 37°C. If necessary, antibiotics were 4 
added at the following concentrations: tetracycline (10 µg/ml), spectinomycin (100 µg/ml), 5 
and chloramphenicol (5 µg/ml). Other supplements were IPTG (1 mM) and xylose (0.5%). 6 
For all cloning procedures Escherichia coli TOP10 was used as the standard plasmid host 7 
(20).  8 
 9 
Construction of bacterial two hybrid plasmids 10 
In order to construct C-terminal truncations of divIVA for use in the bacterial two-hybrid 11 
assay, plasmid p25N-divIVA and pUT18-divIVA were used templates in a PCR with 12 
oligonucleotide 25_N_18_F as the forward and the oligonucleotides divIVA_11_B2H_R 13 
(∆11), divIVA_19_B2H_R (∆20), divIVA_21_R (∆21), divIVA_26_R (∆26), divIVA_34_R 14 
(∆34) as the complementary primers (for all primer sequences see Table 2). The PCR 15 
products were KpnI digested, self-ligated and transformed to E. coli. The appropriate clones 16 
were identified using restriction analysis and DNA sequencing. 17 
 18 
Construction of plasmids containing divIVA from B. subtilis and L. monocytogenes  19 
For xylose-inducible expression of B. subtilis divIVA we constructed plasmid pSH19. This 20 
plasmid was obtained by introducing a stop codon between divIVA and gfp using plasmid 21 
pSH3 as the template and the oligonucleotides SV23/SV24 as the primers in a quick-change 22 
mutagenesis reaction. In order to express the L. monocytogenes divIVA gene in B. subtilis 23 
cells, plasmid pSH209 was constructed. This plasmid contains the complete lmo2020 open 24 
reading frame of L. monocytogenes under control of the Pxyl promoter. It was obtained by 25 
amplification of the L. monocytogenes divIVA DNA fragment with the oligonucleotides 26 
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SHW109/SHW110 and subsequent cloning of the obtained fragment into plasmid pSG1154 1 
using KpnI/XhoI. Plasmid pSH210 was constructed in the same way to allow for the 2 
expression of L. monocytogenes DivIVA-GFP in cells of B. subtilis. However, for this 3 
cloning, the divIVA DNA fragment was amplified with primers SHW109/SHW111 to fuse the 4 
divIVA gene in frame to the gfp gene of the vector backbone. The A206K mutation which 5 
prevents dimerization of GFP (21, 22) was introduced into the gfp part of plasmid pSH210 6 
using quickchange mutagenesis with SHW425/SHW426 as the mutagenic primers. The 7 
resulting plasmid was sequenced and named pSH354. 8 
 9 
Construction of divIVA chimeras  10 
For the construction of chimeric divIVA genes consisting of N-terminal parts from L. 11 
monocytogenes and C-terminal parts from B. subtilis, a PCR based restriction free cloning 12 
strategy was used (23). C-terminal fragments of B. subtilis divIVA gene were amplified from 13 
plasmid pSH19 with SHW237 (pSH260), SHW238 (pSH261), SHW247 (pSH267), SHW265 14 
(pSH272) and SHW266 (pSH278) as the respective forward and SHW184 as the reverse 15 
primer in a first step. All forward primers were identical to the desired fusion sites in the L. 16 
monocytogenes divIVA gene in their 5´-regions, whereas the reverse primer SHW184 17 
annealed outside the B. subtilis divIVA gene in the pSH19 plasmid backbone. For the 18 
construction of the divIVABs-57-Lm chimera, a DNA fragment corresponding to the first 57 19 
amino acids of the B. subtilis divIVA gene was amplified in a PCR with pSH19 as template 20 
and SHW354 and SHW355 as the primers. All PCR products were purified using the PCR 21 
purification kit from Qiagen and used as mega primers in a second PCR with plasmid pSH209 22 
as template in order to fuse the N- and C-terminal fragments of B. subtilis divIVA to the 23 
corresponding portions of the L. monocytogenes divIVA gene. For the construction of the 24 
divIVABs-57-Lm chimera (pKK13), primer SHW180 was added as a reverse primer to the PCR 25 
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mixture. The PCR mixtures were then DpnI digested, transformed and the correct clones were 1 
identified using restriction analysis and DNA sequencing. 2 
GFP was fused to all DivIVA chimeras by replacing the stop codon of the chimeric divIVA 3 
genes by a glycine codon in a way that the divIVA genes was fused to the downstream gfp 4 
ORF that was already present in these plasmids. For this purpose we used the 5 
oligonucleotides SHW304/SHW305 to replace the divIVA stop codons in plasmids pSH260, 6 
pSH261, pSH267, pSH272, and pSH278. The replacement of the divIVA stop codon in 7 
plasmid pKK13 was performed using the primer pair SHW366/SHW367. The DNA sequence 8 
of all plasmid clones was verified and the plasmids were named pSH290 (divIVALm-71-Bs-9 
gfpA206K), pSH291 (divIVALm-144-Bs-gfpA206K), pSH292 (divIVALm-130-Bs-gfpA206K), 10 
pSH293 (divIVALm-83-Bs-gfpA206K), pSH294 (divIVALm-104-Bs-gfpA206K), and pSH326 11 
(divIVABs-57-Lm-gfp). Finally, the gfpA206K mutation was also introduced into plasmid pSH326 12 
as described above to result in plasmid pSH355. 13 
 14 
 Construction of a minJ-gfp fusion 15 
In order to express a minJ-gfp fusion in the divIVA chimera strains, the minJ-gfp allele of 16 
strain SB002 was PCR amplified using the oligonucleotides SHW342/SHW343, cut 17 
BamHI/SalI, ligated to pAPNC213cat digested with the same enzymes, and the resulting 18 
plasmid was named pSH316 after DNA sequencing. However, there was only marginal MinJ-19 
GFP fluorescence, when pSH316 was inserted into the B. subtilis chromosome under inducing 20 
conditions (strain BSN308, data not shown). Therefore, plasmid pSH317 was constructed in 21 
which the lacI gene of pSH316 was deleted by PCR using the primer pair SHW349/SHW350 22 
in order to enhance the fluorescence signal. MinJ-GFP fluorescence was still not sufficient 23 
with this allele (strain BSN317, data not shown), so the promoter region of the B. subtilis 24 
divIVA gene including the ribosomal binding site was amplified with primers SV98/SHW356, 25 
cut with KpnI and XhoI, and ligated to pSH317 which had been cut with the same enzymes. 26 
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Two clones were isolated that contained a divIVA promoter insert of the right size but DNA 1 
sequencing revealed single mutations in the RBS (PdivIVA1 on pSH320). In order to correct this, 2 
quick-change mutagenesis with primers SHW357/SHW358 was employed on pSH320 and 3 
several plasmid clones were isolated and transformed to B. subtilis. From these 4 
transformations, only three plasmid clones conferred the typical fluorescence pattern of MinJ-5 
GFP on cells of B. subtilis. When sequenced, one of these clones had a corrected RBS but 6 
also an unintended G deletion between the RBS and the MinJ-GFP start codon (PdivIVA3). This 7 
clone was named pSH328 and used for all further studies. 8 
 9 
Construction of point mutations and C-terminal truncations in divIVA 10 
For the construction of plasmid pINC12 encoding the divIVAR131A gene under control of the 11 
Pspac promoter, we made use of plasmid pINC3 which already contained the divIVAR131A-gfp 12 
allele. pINC3 was originally obtained by quick change mutagenesis using the mutagenesis 13 
primers R131A_fw/R131A_rev on plasmid pDG9. divIVAR131A of pINC3 was then 14 
amplified using the primers SV123/SV81, the resulting PCR fragment was cut with 15 
BamHI/SalI, and ligated to the BamHI/SalI cut vector backbone of plasmid pAPNC213. The 16 
DNA sequence of one clone was verified and this clone was named pINC12. The R102K, 17 
R102E, and ΔC34 mutations were introduced into plasmid pSH2 by quick-change 18 
mutagenesis using the oligonucleotides SHW378/SHW379 (pSH330), SHW380/SHW381 19 
(pSH331), and SHW386/SHW387 (pSH334), respectively. In order to exchange the spc 20 
marker by a cat cassette in these plasmids, the KpnI/SacI Pspac-divIVA fragments of pSH2, 21 
pSH330, pSH331, and pSH334 were then sub-cloned into the KpnI/SacI cut backbone of 22 
pAPNC213cat in a second step. The resulting plasmids were sequenced and named pSH335 23 
(wt), pSH336 (R102K), pSH337 (R102E), and pSH340 (ΔC34). 24 
 25 
 9
Strain construction 1 
Plasmids designed for the expression of divIVA alleles in B. subtilis were inserted into the 2 
amyE gene of B. subtilis 168 and amylase negative transformants were selected based on 3 
iodine staining of starch containing agar plates. Alternatively, the aprE locus was also used 4 
for chromosomal integrations. Insertions at aprE were generally confirmed by PCR. 5 
Combinations of alleles were generated by transformation (24). 6 
 7 
Bacterial two-hybrid analysis 8 
In order to investigate the interaction of the DivIVA and C-terminally truncated DivIVA 9 
proteins with MinJ and RacA, the bacterial two-hybrid system was used (25). Plasmids 10 
encoding divIVA alleles fused to the T18- or the T25- fragment of the Bordetella pertussis 11 
adenylate cyclase were co-transformed in E. coli BTH101 along with plasmids encoding T25- 12 
and T18-fusions to RacA and MinJ. Transformants were selected on nutrient agar plates 13 
containing ampicillin (100 µg/ml), kanamycin (50 µg/ml), X-Gal (0.004%) and IPTG (0.1 14 
mM) and photographs were taken after 40 h of growth at 30°C. 15 
 16 
Microscopic techniques 17 
For microscopy of bacterial cells, a small volume (0.3 µl) of an exponentially growing culture 18 
was mounted on a microscope slide covered with a thin film of 1.5% agarose (dissolved in 19 
distilled water). Membranes were stained using FM5-95. Images were taken with a Nikon 20 
Eclipse Ti microscope coupled to a Nikon DS-MBWc CCD camera and processed using the 21 
NIS elements AR software package (Nikon). 22 
 23 
Sporulation assays 24 
B. subtilis strains were streaked on Schaeffer´s sporulation agar (26) containing 0.5% xylose 25 
or 1 mM IPTG and incubated for up to seven days at 37°C until lysis of the translucent 26 
 10
sporulation-deficient strains could be comfortably discriminated from the optically dense 1 
appearance of sporulation-proficient strains. Plates were photographed against a black 2 
background. 3 
 4 
Isolation of cellular proteins, PAGE techniques and Western blotting 5 
Exponentially growing cells of B. subtilis were harvested by centrifugation (13.000 rpm for 1 6 
min in an Eppendorf 5415R table top centrifuge) and the cell pellet was washed once in ZAP 7 
buffer (10 mM Tris-HCl pH 7.5, 200 mM NaCl). Cells were disrupted by sonication in ZAP 8 
buffer containing 1 mM PMSF and cell debris was pelleted in another centrifuge run. 9 
Aliquots of the resulting supernatant were either separated by SDS PAGE or by blue native 10 
PAGE which was performed using NativePAGETM Novex ® 4-16% Bis-Tris gels (Invitrogen) 11 
and carried out according to the instructions given by the manufacturer. Subsequently, gels 12 
were blotted onto a polyvinylidene difluoride (PVDF) membrane employing a semi-dry 13 
electroblotting unit. Proteins of interest were visualised using polyclonal rabbit antisera 14 
recognizing DivIVA (5) or GFP (lab stock) as the primary antibodies and an anti-rabbit 15 
immunoglobulin G conjugated to horseradish peroxidase as the secondary one. The ECL 16 
chemiluminescence detection kit (Thermo Scientific) was then used for the detection of the 17 





C-terminal DivIVA truncations interfere with MinJ and RacA binding 2 
The tetramerization domain of B. subtilis DivIVA is followed by 11 non-conserved amino 3 
acid residues. The atomic structure of this C-terminal stretch could not be solved using 4 
crystallography, suggesting that it is a flexible tail. To determine whether this C-terminal tail 5 
is involved in the binding of MinJ and/or RacA, we made use of the bacterial two-hybrid 6 
assay and cloned two DivIVA truncations in this system: DivIVAΔ11 lacking the last 11 C-7 
terminal amino acids, and DivIVAΔ20 which lacks the last 20 C-terminal amino acids 8 
including a part of the tetramerization domain (Table 3). Both truncations were still able to 9 
interact with full-length DivIVA, indicating that both mutants are expressed normally and can 10 
form dimers (Table 3, a colored image of the bacterial two-hybrid plate is available in Fig. 11 
S1). MinJ interacted strongly with full length DivIVA and with both DivIVA truncations in 12 
the bacterial two-hybrid assay, whereas RacA showed a weak interaction with full length 13 
DivIVA that was abolished when the last 11 amino acids of DivIVA were removed (Table 3, 14 
Fig. S1). It seems that the RacA-DivIVA interaction depends on the 11 C-terminal amino 15 
acids of DivIVA, whereas the MinJ contact site is located more to the N-terminus of DivIVA. 16 
To test this, additional DivIVA truncations were constructed: DivIVAΔ21, DivIVAΔ26, and 17 
DivIVAΔ34, which successively removed the complete tetramerization domain. The latter 18 
two truncations, DivIVAΔ26 and DivIVAΔ34, were severely impaired in their ability to 19 
interact with MinJ (Table 3, Fig. S1), suggesting that the tetramerization domain contains 20 
residues required for MinJ binding. 21 
 22 
Importance of the tetramerization domain for DivIVA activity 23 
The bacterial two-hybrid assay also revealed a weakened interaction of the DivIVAΔ26 24 
(corresponding to DivIVA amino acids 1-138) and DivIVAΔ34 (1-130) truncations with full-25 
length DivIVA whereas DivIVAΔ21 (1-143) still behaved normal (Table 3, Fig. S1). So far 26 
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there is no biochemical corroboration that amino acids 130-143 are involved in 1 
tetramerization in vivo. Own preliminary alanine mutagenesis experiments in this region 2 
identified R131 as an essential residue for DivIVA activity (Fig. S3 A-C) suggesting a special 3 
importance of this region for DivIVA function. Thus, DivIVAΔC34 was expressed in a 4 
ΔdivIVA mutant (strain BSN360) and phenotypic analysis of this strain clearly demonstrated 5 
the inability of the divIVAΔC34 allele to complement the cell division and the sporulation 6 
phenotype of the ΔdivIVA mutation (Fig. 2A-B) even though DivIVAΔC34 was clearly 7 
expressed (Fig. 2C, upper panel). Blue native PAGE of strain BSN356 expressing wild-type 8 
DivIVA showed that DivIVA exists in two different oligomeric states since two signals of 9 
different molecular weight were detected by the DivIVA antiserum (Fig. 2C, bottom panel). 10 
The molecular weight was calculated to be 159±8 kDa for the upper and 41±13 kDa for the 11 
lower signal in the wild type cell extract. Given the molecular weight of Bs DivIVA (19.34 12 
kDa), these molecular weights correspond to an octamer and a dimer, respectively. Blue 13 
native PAGE of strain BSN360 revealed the existence of a dimer signal (Fig. 2C, bottom 14 
panel). Previous gel filtration analyses have indicated that purified DivIVA forms octamers 15 
and higher-order structures (18, 27). Therefore it seems plausible that the region beyond 16 
residue 130 indeed contains the tetramerization domain, and that tetramerization is a 17 
prerequisite step for octamerization. 18 
 19 
Domain swapping to identify DivIVA interaction domains 20 
It is possible that C-terminal truncations used in the bacterial two-hybrid system result in 21 
misfolded and/or instable DivIVA variants. This complicates the interpretation of the bacterial 22 
two-hybrid data. Because of this we changed tactics and explored the possibility to swap 23 
domains between B. subtilis DivIVA and the closely homologous DivIVA from L. 24 
monocytogenes. In a previous study, we have shown that L. monocytogenes DivIVA displays 25 
the same localization pattern as B. subtilis DivIVA, and is involved in SecA2-dependent 26 
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protein secretion (10). L. monocytogenes does not sporulate and does not contain a RacA 1 
homologue. It is also unlikely that L. monocytogenes DivIVA interacts with MinJ since 2 
deletion of the divIVA gene does not result in a mini-cell phenotype in L. monocytogenes, 3 
indicating that the listerial division site control system is DivIVA-independent (10). This 4 
would enable us to separate the DivIVA domains required for localization and for RacA and 5 
MinJ interaction. First it was necessary to confirm that L. monocytogenes DivIVA is normally 6 
localized when expressed in B. subtilis. Indeed, L. monocytogenes DivIVA fused to GFP and 7 
expressed in a divIVA knock-out background (strain BSN373) shows a localization pattern 8 
that is similar to that of Bs DivIVA (Fig. 3) even though Lm DivIVA predominantely exists as 9 
a dimer and just to a minor extent in an oligomeric form when expressed in B. subtilis (Fig. 10 
S2). More importantly however, Lm DivIVA does not complement the cell division and 11 
sporulation defects of a B. subtilis ΔdivIVA mutant (strain BSN238, Fig. 5A-B). Thus, Lm 12 
DivIVA seems unable to bind MinJ and RacA, and is therefore well suited for domain 13 
swapping. 14 
The most prominent difference between Lm and Bs DivIVA  is found in the C-terminal 15 
tail (Fig. 4A), which is 11 amino acids longer in the L. monocytogenes protein, and which has 16 
been shown to be important for binding RacA according to the bacterial two-hybrid data. To 17 
test this, a DivIVA chimera was constructed by replacing the last 32 amino acids of Lm 18 
DivIVA with the last 21 amino acids of Bs DivIVA (Lm-144-Bs), so that the C-terminal tails 19 
were exchanged between both proteins whereas the core tetramerization domain (130-143) 20 
was left intact (Fig. 4B). Expression of this chimera in a B. subtilis ∆divIVA background 21 
(strain BSN274) did neither restore cell division nor sporulation (Fig. 5A,B). Western blotting 22 
showed that Lm-144-Bs DivIVA was stably expressed and not degraded (Fig. 4C). The 23 
chimeric protein localized normally, as a GFP fusion indicated (strain BSN295, Fig. S4) and 24 
formed a stable oligomer (Fig. S2), suggesting that the last 21 amino acids of Bs DivIVA 25 
alone are insufficient for binding of MinJ or RacA. 26 
 14
Systematic domain swapping 1 
Since RacA binding seems to require a larger part of Bs DivIVA we constructed a set of 2 
chimeric DivIVA proteins in which the fusion point between the N-terminal L. 3 
monocytogenes and the C-terminal B. subtilis parts was shifted from the tail region towards 4 
the N-terminus of the C-terminal domain in a stepwise fashion, as schematically indicated in 5 
Fig. 4B. Position 130 exchanged the complete C-terminus beginning from the TD, positions 6 
104 and 83 mark the beginning of short stretches in the coiled coil region at which both 7 
proteins differ at three to four consecutive amino acid positions, whereas the domain swap at 8 
position 71 exchanged the complete C-terminal domain behind the flexible linker (Fig. 4A-B). 9 
Stability and oligomerization of the chimeras was checked by Western blotting indicating that 10 
all the chimeric DivIVA proteins were expressed at comparable levels (Fig. 4C) and were 11 
oligomeric (Fig. S2). Expression of these chimeras in the B. subtilis ∆divIVA background did 12 
not restore normal vegetative cell division (Fig. 5A) suggesting that they were unable to 13 
recruit MinJ. Of the different chimera, only the Lm-104-Bs DivIVA chimera was able to 14 
restore spore formation. To confirm that the Lm-104-Bs DivIVA chimera was indeed able to 15 
recruit RacA and not MinJ, the chimera was expressed in ΔdivIVA mutant strains either 16 
containing the GFP-RacA or the MinJ-GFP reporter. As shown in Fig. 6A-B, the Lm-104-Bs 17 
DivIVA chimera can recruit RacA but not MinJ. In conclusion, the RacA interaction domain 18 
resides in the last 60 amino acids of DivIVA and requires residues in the coiled-coiled region 19 
beyond amino acid 104.  20 
 It is surprising that larger replacements of the C-terminus (as in Lm-71-Bs and Lm-83-21 
Bs) are again unable to restore sporulation. A possibility is that these chimeras do not localize 22 
properly anymore. To test this, we expressed C-terminal GFP fusions to the chimeric DivIVA 23 
constructs, and analysed their localization in B. subtilis ∆divIVA cells. Expression of all 24 
DivIVA-GFP proteins gave rise to polar and septal fluorescence signals, however, to different 25 
degrees (Fig. S4A). While DivIVALm-144-Bs-GFP and DivIVALm-130-Bs-GFP clearly 26 
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accumulated at the division septa, septal fluorescence signals of DivIVALm-104-Bs-GFP, 1 
DivIVALm-83-Bs-GFP, and DivIVALm-71-Bs-GFP were less intense but still visible (Fig. S4A). 2 
This suggests that all DivIVA chimeras are functional in terms of lipid binding and membrane 3 
curvature sensing. 4 
 5 
The lipid binding domain recruits MinJ 6 
As none of the chimeras was able to complement the cell division phenotype, it may be that 7 
regions in the N-terminal domain are critical for the interaction of Bs DivIVA with MinJ. To 8 
test this, we fused the N-terminal 57 amino acids of B. subtilis DivIVA spanning the entire 9 
lipid binding domain to the complete C-terminal domain of L. monocytogenes DivIVA (Fig. 10 
4B). When this DivIVA chimera was expressed in a ∆divIVA background (strain BSN321), 11 
short cells and no mini-cells were observed (Fig. 5A), indicating that the Bs-57-Lm DivIVA 12 
protein recruits MinJ. The localization as well as oligomerization of this chimera is 13 
comparable to wild type DivIVA (Fig. S4 and Fig. S2, respectively) and indeed restores 14 
normal septal and polar localization of GFP-MinJ (Fig. 6A). Strikingly, sporulation was still 15 
defective in strain BSN321 (Fig. 5B) and the Bs-57-Lm chimera is unable to recruit RacA 16 
(Fig. 6B). In conclusion, the lipid binding N-terminal domain of DivIVA contains the MinJ 17 




Here we show that two of the DivIVA interaction partners from B. subtilis, MinJ and RacA, 2 
bind to mutually exclusive surface regions of DivIVA. This was concluded from 3 
complementation assays with DivIVA chimeras constructed from B. subtilis and L. 4 
monocytogenes DivIVA. Analysis of a set of such DivIVA chimeras in complementation 5 
experiments surprisingly revealed that the N-terminal lipid binding domain provides the MinJ 6 
interaction module whereas RacA binds to the C-terminal domain of DivIVA. This was 7 
unexpected since it was assumed that the C-terminal domain would constitute the protein 8 
recruitment module for both proteins, with the LBD being important only for dimerization 9 
and lipid binding. However, a dual function of the lipid binding domain is in good agreement 10 
with the two-domain nature of DivIVA proteins. The lipid binding domain is in close contact 11 
to the cytoplasmic membrane and even partially inserts into it, which makes it a good 12 
candidate for interacting with trans-membrane proteins like MinJ. Since most sequence 13 
differences between the LBDs of Bs and Lm DivIVA cluster between residues E28 and I57 14 
(Fig. 4A), this region most likely represents the MinJ binding surface of DivIVA. Support for 15 
this assumption comes from the observation that a replacement of region 1-16 of 16 
Corynebacterium glutamicum DivIVA by the corresponding region from Bs DivIVA was 17 
without effect (19). Lipid binding of DivIVA via its N-terminal domain would in turn leave 18 
the C-terminus free to reach into the cytoplasm. Fitting with this, our experiments indicated 19 
that the C-terminal domain is the interaction module for RacA which is a soluble cytoplasmic 20 
protein. It was recently reported that the interaction of C. glutamicum ParB, which is a 21 
chromosome-binding protein like RacA, to its cognate DivIVA requires central regions of the 22 
C-terminal domain as well (9). Our results thus confirm earlier speculations that the 23 
sporulation and the division functions of DivIVA can be separated. This had been concluded 24 
from the observation that a divIVAN99D mutation severely affected sporulation but not 25 
division (28). Another classical divIVA point mutation is the divIVA1 mutation in which the 26 
 17
alanine at position 78 is substituted by a threonine. This mutation causes a div– spo– phenotype 1 
(29) even though it lies outside the RacA and MinJ binding regions. Neither expression nor 2 
oligomerization of DivIVA is impaired by this mutation (30). Thus, the A78T exchange might 3 
possibly affect subcellular localisation of DivIVA or induce structural changes in the protein 4 
that reduce its activity but do not influence formation of oligomers. 5 
The question that we cannot answer conclusively is: Why do the two chimeras with the more 6 
N-terminally located fusion points (Lm-83-Bs and Lm-71-Bs) not behave similar to the Lm-7 
104-Bs DivIVA protein? Initially, this conflicted with the idea that C-terminal domain is the 8 
protein recruitment module for RacA, since longer C-terminal exchanges than in Lm-104-Bs 9 
should result at least in the same degree of complementation activity. We do not think that 10 
this is explained by misfolding of the respective chimeric proteins since they still oligomerize 11 
(Fig. S2) and because GFP-tagged versions of these chimeras still localised to the septum in 12 
the same degree as the Lm-104-Bs GFP fusion protein (Fig. S4A) and therefore appeared to be 13 
folded properly. Moreover, a strain expressing an Lm-57-Bs DivIVA protein showed the same 14 
sporulation defect as strains expressing Lm-83-Bs and Lm-71-Bs DivIVA chimeras (data not 15 
shown). Possibly, longer C-terminal exchanges do not function in the context of an unrelated 16 
lipid binding domain. With regard to this issue, the fact that the arginine 102 residue of Bs 17 
DivIVA is phosphorylated might be of special interest here (31). This phosphorylation could 18 
be critical for RacA recruitment and may add an extra dimension of activity control on the 19 
different DivIVA chimeras. Therefore, we constructed a phospho-ablative (R102K) and a 20 
phospho-mimetic (R102E) mutant allele of divIVA and tested their activity in our 21 
complementation system. Both of these mutations cause a div+ spo– phenotype (Fig. S5). 22 
Hence, arginine 102 might indeed have a crucial function in RacA binding but it is not 23 
relevant for the interaction with MinJ. Phosphorylations at the C-terminal domains are well 24 
described for DivIVA from Mycobacterium tuberculosis (named Wag31 in mycobacteria) and 25 
Streptococcus pneumoniae even though they both occurred at threonine side chains (T73 and 26 
 18
T201, respectively). Phenotypic analysis of phospho-mimetic and phospho-ablative divIVA 1 
mutant strains in these organisms also revealed that these phosphorylations are indeed 2 
involved in cell shape control (32, 33). In the future it will be interesting to address the 3 
regulatory impact of such phosphorylations for DivIVA binding partner recruitment. 4 
 5 
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FIGURE LEGENDS 1 
 2 
Figure 1: Domain arrangement of B. subtilis DivIVA. (A) Schematic sequence alignment of 3 
DivIVA proteins of different phylogenetic origin. Abbreviations above the alignment label the 4 
individual protein regions: LBD – lipid binding domain, CTD – C-terminal domain, TD – 5 
tetramerization domain, tail – C-terminal tail region. Amino acid numbering is according to B. 6 
subtilis DivIVA. (B) Model of the crystal structure of the full-length B. subtilis DivIVA 7 
tetramer which has been assembled from the individual crystal structures of the N- and the C-8 
terminal domains (18). Crystallographic data for the linker between both domains are not 9 
available (residues 53-70). Amino acid positions at the beginning and the end of the lipid 10 
binding domain as well as the C-terminal domain are indicated for one molecule. Truncation 11 
sites of DivIVAΔC26 and DivIVAΔC34 at positions 138 and 130, respectively, are also 12 
shown (compare Table 3). 13 
 14 
Figure 2: Complementation activity and oligomerization of a C-terminally truncated DivIVA 15 
protein devoid of the tetramerization domain. (A) Phase contrast micrographs showing 16 
cellular morphology of strain BSN360 expressing the DivIVAΔC34 protein. Cultures of strain 17 
168 (wt), strain 4041 (ΔdivIVA) and the complemented ΔdivIVA mutant strain BSN356 18 
(+divIVA) were included for control. Cells were cultivated in LB broth (containing 1 mM 19 
IPTG where necessary) to mid-logarithmic growth phase at 37°C before images were taken. 20 
Scale bar is 5 µm. (B) Sporulation of the same set of strains on Schaeffers sporulation agar 21 
containing 1 mM IPTG. Cells were kept for 3 days at 37°C until lysis of the spo– strains 22 
became apparent. (C) Western blots after SDS-PAGE and blue native PAGE to analyse 23 
expression and oligomerization of DivIVAΔC34. Strains BSN356 (+divIVA) and BSN360 24 
(+ΔC34) were cultivated as described above and cellular protein extracts were subjected to 25 
SDS-PAGE (upper panel) or blue native PAGE (bottom panel) and subsequent Western 26 
blotting. DivIVA was detected using the polyclonal anti-DivIVA antiserum. The 27 
 23
NativeMarkTM standard (Invitrogen) was used as a molecular weight marker for blue native 1 
PAGE. 2 
 3 
Figure 3: Localization of L. monocytogenes DivIVA-GFP in a B. subtilis ∆divIVA 4 
background. Strain BSN373 (expressing Lm DivIVA-GFPA206K) was grown in LB 5 
supplemented with 0.5% xylose. The localization pattern of Lm DivIVA-GFP was analysed 6 
by epifluorescence microscopy (right image), and for orientation, a FM5-95 stained image 7 
(left panel) was taken in parallel. Scale bar is 5 µm, several septal DivIVA-GFP signals are 8 
indicated by arrows. 9 
 10 
Figure 4: Expression of Lm/Bs DivIVA chimeras in B. subtilis. (A) Sequence alignment of 11 
the DivIVA proteins from B. subtilis (Bs) and L. monocytogenes (Lm). Identical amino acid 12 
positions are indicated by a black, similar amino acid positions by a grey background. The 13 
exchange sites in the different chimeras are labelled by asterisks. (B) Schematic illustration of 14 
the domain organisation of the Bs and Lm DivIVA proteins and composition of all Lm/Bs 15 
DivIVA chimeras. Abbreviations are as in Fig. 1A. The complementation activity of the 16 
DivIVA chimeras in the complementation assays for division (div) and sporulation (spo) is 17 
indicated in the table on the right side (compare Fig. 5). (C) Western blot showing expression 18 
of the DivIVA chimeras in a B. subtilis ΔdivIVA background. The wild type strain 168 and the 19 
ΔdivIVA mutant (4041) as well as strains expressing B. subtilis divIVA (BSN51) or L. 20 
monocytogenes divIVA (BSN238) were included as controls and the DivIVA proteins were 21 
detected with an antiserum that had been raised against B. subtilis DivIVA (5). 22 
  23 
Figure 5: Complementation activity of Lm/Bs DivIVA chimeras in the B. subtilis ΔdivIVA 24 
background. (A) Phase contrast micrographs showing the ability of the tested Lm/Bs DivIVA 25 
chimeras to complement the filamentous ∆divIVA phenotype. Cells were cultivated in LB 26 
 24
broth containing 0.5% xylose until mid-log growth phase at 37°C before cell morphology was 1 
assessed microscopically. Scale bar is 5 µm. (B) Sporulation plate assay to test the activity of 2 
the Lm/Bs DivIVA chimeras to complement the sporulation defect of the B. subtilis ΔdivIVA 3 
mutant. Strains expressing the DivIVA chimeras were streaked on Schaeffer´s sporulation 4 
agar containing 0.5% xylose and kept at 37°C until lysis of non-sporulating strains was 5 
comfortably distinguishable from the brownish spo+ strains. The wild type, the ΔdivIVA 6 
mutant and strains complemented either with the B. subtilis (BSN51) or the L. monocytogenes 7 
divIVA gene (BSN238) were used as controls. 1 – strain 168 (wt), 2 – strain 4041 (∆divIVA), 3 8 
– strain BSN51 (+Bs divIVA), 4 – strain BSN238 (+Lm divIVA), 5 – strain BSN274 (+Lm-9 
144-Bs divIVA), 6 – strain BSN278 (+Lm-130-Bs divIVA), 7 – strain BSN288 (+Lm-104-Bs 10 
divIVA), 8 – strain BSN287 (+Lm-83-Bs divIVA), 9 – strain BSN316 (+Lm-71-Bs divIVA), 10 11 
– strain BSN321 (+Bs-57-Lm divIVA). Please note that sporulation of strain strain BSN288 12 
(+Lm-104-Bs divIVA) did not reach wild type level. This might be explained by the lack of 13 
MinCD activity in this strain which is required for full sporulation (34). 14 
 15 
Figure 6: Localization of MinJ and RacA in B. subtilis strains expressing selected Lm/Bs 16 
divIVA chimeras. (A) Fluorescence micrographs showing the subcellular localization of MinJ-17 
GFP in Lm/Bs divIVA chimera strains during mid-logarithmic growth in LB broth 18 
supplemented with 0.5% xylose at 37°C (top row). MinJ-GFP was imaged in strains 19 
expressing Lm-104-Bs DivIVA (strain BSN336) and the Bs-57-Lm DivIVA chimera (strain 20 
BSN338). For control, MinJ-GFP was also visualised in ∆divIVA strains which express Bs 21 
divIVA (strain BSN334) or Lm divIVA (strain BSN335). Phase contrast images were included 22 
for better orientation (bottom row). (B) Localization of RacA in B. subtilis strains expressing 23 
the same Lm/Bs divIVA chimeras as in panel A. Fluorescence images were obtained on cells 24 
during growth in LB broth containing 0.5% xylose at 37°C (top row). GFP-RacA was 25 
visualized in strains expressing the Lm-104-Bs DivIVA (strain BSN342) and Bs-57-Lm 26 
 25
DivIVA (strain BSN344). As controls, GFP-RacA was also imaged in strain BSN340 1 
expressing Bs divIVA and in strain BSN341 which expresses Lm divIVA. Phase contrast 2 




Table 1: Plasmids and strains used in this study 1 
Name relevant characteristics source*/ 
reference 
Plasmids 
pAPNC213 bla aprE5' spc lacI Pspac aprE3' (35) 
pAPNC213cat bla aprE5' cat lacI Pspac aprE3' H. Strahl  
pDG9 bla amyE3' spc Pxyl-divIVA-gfp amyE5' (18) 
pSG1154 bla amyE3' spc Pxyl-`gfp amyE5' (36) 
pSH2 bla aprE5' spc lacI Pspac-divIVA
Bs aprE3' (18) 
pSH3 bla amyE3' spc Pxyl-divIVA
Bs-gfpA206K amyE5' (18) 
pKT25-racA kan Plac-cya(T25)-racA (1) 
pUT18-divIVA bla Plac-cya(T18)-divIVA (1) 
pUT18C-divIVA bla Plac-cya(T18)-divIVA (11) 
pUT18C-minJ bla Plac-cya(T18)-minJ (11) 
pUT18C-racA bla Plac-cya(T18)-racA (1) 
p25-N-divIVA kan Plac-divIVA-cya(T25) (1) 
p25-N-minJ kan Plac-minJ-cya(T25) (11) 
pINC3 bla amyE3' spc Pxyl-divIVAR131A-gfp amyE5' this work 
pINC12 bla aprE5' spc lacI Pspac-divIVA R131A aprE3' this work 
pKK13 bla amyE3' spc Pxyl- divIVA
Bs-57-Lm amyE5' this work 
pSBLH001 bla Plac-divIVA
1-459(∆11)-cya(T18) this work 
pSBLH004 kan Plac-divIVA
1-459(∆11)-cya(T25) this work 
pSBLH005 bla Plac-divIVA
1-432(∆20)-cya(T18) this work 
pSBLH008 kan Plac-divIVA
1-432(∆20)-cya(T25) this work 
pSBLH036 bla Plac-divIVA
1-429(∆21)-cya(T18) this work 
pSBLH037 bla Plac-divIVA
1-414(∆26)-cya(T18) this work 
pSBLH038 bla Plac-divIVA
1-390(∆34)-cya(T18) this work 
pSBLH039 kan Plac-divIVA
1-429(∆21)-cya(T25) this work 
pSBLH040 kan Plac-divIVA
1-414(∆26)-cya(T25) this work 
pSBLH041 kan Plac-divIVA
1-390(∆34)-cya(T25) this work 
pSH19 bla amyE3' spc Pxyl-divIVA
Bs amyE5' this work 
pSH209 bla amyE3' spc Pxyl- divIVA
Lm amyE5' this work 
pSH210 bla amyE3' spc Pxyl- divIVA
Lm-gfp amyE5' this work 
pSH260 bla amyE3' spc Pxyl- divIVA
Lm-71-Bs amyE5' this work 
pSH261 bla amyE3' spc Pxyl- divIVA
Lm-144-Bs amyE5' this work 
pSH267 bla amyE3' spc Pxyl- divIVA
Lm-130-Bs amyE5' this work 
pSH272 bla amyE3' spc Pxyl- divIVA
Lm-83-Bs amyE5' this work 
pSH278 bla amyE3' spc Pxyl- divIVA
Lm-104-Bs amyE5' this work 
pSH290 bla amyE3' spc Pxyl- divIVA
Lm-71-Bs-gfpA206K amyE5' this work 
pSH291 bla amyE3' spc Pxyl- divIVA
Lm-144-Bs-gfpA206K amyE5' this work 
pSH292 bla amyE3' spc Pxyl- divIVA
Lm-130-Bu-gfpA206K amyE5' this work 
pSH293 bla amyE3' spc Pxyl- divIVA
Lm-83-Bs-gfpA206K amyE5' this work 
pSH294 bla amyE3' spc Pxyl- divIVA
Lm-104-Bs-gfpA206K amyE5' this work 
pSH316 bla aprE5' cat lacI Pspac-minJ-gfp aprE3' this work 
pSH317 bla aprE5' cat Pspac-minJ-gfp aprE3' this work 
pSH320 bla aprE5' cat PdivIVA1-minJ-gfp aprE3' this work 
pSH326 bla amyE3' spc Pxyl- divIVA
Bs-57-lm-gfp amyE5' this work 
pSH328 bla aprE5' cat PdivIVA3-minJ-gfp aprE3' this work 
pSH330 bla aprE5' spc lacI Pspac-divIVA
BsR102K aprE3' this work 
pSH331 bla aprE5' spc lacI Pspac-divIVA
BsR102E aprE3' this work 
pSH334 bla aprE5' spc lacI Pspac-divIVA
BsΔC34 aprE3' this work 
pSH335 bla aprE5' cat lacI Pspac-divIVA
Bs aprE3' this work 
pSH336 bla aprE5' cat lacI Pspac-divIVA
BsR102K aprE3' this work 
pSH337 bla aprE5' cat lacI Pspac-divIVA
BsR102E aprE3' this work 
pSH340 bla aprE5' cat lacI Pspac-divIVA
BsΔC34 aprE3' this work 
pSH354 bla amyE3' spc Pxyl- divIVA
Lm-gfpA206K amyE5' this work 
pSH355 bla amyE3' spc Pxyl- divIVA
Bs-57-lm-gfpA206K amyE5' this work 
   
B. subtilis strains 
168 trpC2  
168 (pSG4916) 168 racA::pSG4916(Pxyl-gfp-racA´ cat) (8) 
 27
Name relevant characteristics source*/ 
reference 
4041 168 divIVA::tet (18) 
BSN5 168 aprE::Pspac-divIVA spc lacI divIVA::tet (18) 
SB002 168 amyE::Pxyl-minJ-gfp spc minJ::tet (37) 
BSN51 168 amyE::Pxyl-divIVA
Bs spc divIVA::tet this work 
BSN238 168 amyE::Pxyl- divIVA
Lm spc divIVA::tet this work 
BSN274 168 amyE::Pxyl- divIVA
Lm-144-Bs spc divIVA::tet this work 
BSN278 168 amyE::Pxyl- divIVA
Lm-130-Bs spc divIVA::tet this work 
BSN287 168 amyE::Pxyl- divIVA
Lm-83-Bs spc divIVA::tet this work 
BSN288 168 amyE::Pxyl- divIVA
Lm-104-Bs spc divIVA::tet this work 
BSN294 168 amyE::Pxyl- divIVA
Lm-71-Bs-gfpA206K spc divIVA::tet this work 
BSN295 168 amyE::Pxyl- divIVA
Lm-144-Bs-gfpA206K spc divIVA::tet this work 
BSN296 168 amyE::Pxyl- divIVA
Lm-130-Bs-gfpA206K spc divIVA::tet this work 
BSN297 168 amyE::Pxyl- divIVA
Lm-83-Bs-gfpA206K spc divIVA::tet this work 
BSN298 168 amyE::Pxyl- divIVA
Lm-104-Bs-gfpA206K spc divIVA::tet this work 
BSN308 168 aprE::Pspac-minJ-gfp cat lacI this work 
BSN313 168 aprE::Pspac-divIVA R131A spc lacI divIVA::tet this work 
BSN316 168 amyE::Pxyl- divIVA
Lm-71-Bs spc divIVA::tet this work 
BSN317 168 aprE::Pspac-minJ-gfp cat this work 
BSN321 168 amyE::Pxyl- divIVA
Bs-57-Lm spc divIVA::tet this work 
BSN332 168 aprE::PdivIVA3-minJ-gfp cat  this work 
BSN333 168 aprE::PdivIVA3-minJ-gfp cat divIVA::tet this work 
BSN334 168 aprE::PdivIVA3-minJ-gfp cat amyE::Pxyl-divIVA
Bs spc divIVA::tet this work 
BSN335 168 aprE::PdivIVA3-minJ-gfp cat amyE::Pxyl-divIVA
Lm spc divIVA::tet this work 
BSN336 168 aprE::PdivIVA3-minJ-gfp cat amyE::Pxyl- divIVA
Lm-104-Bs spc divIVA::tet this work 
BSN338 168 aprE::PdivIVA3-minJ-gfp cat amyE::Pxyl -divIVA
Bs-57-Lm spc divIVA::tet this work 
BSN340 168 racA::pSG4916(Pxyl-gfp-racA´cat) amyE::Pxyl-divIVA
Bs spc divIVA::tet this work 
BSN341 168 racA::pSG4916(Pxyl-gfp-racA´cat) amyE::Pxyl-divIVA
Lm spc divIVA::tet this work 
BSN342 168 racA::pSG4916(Pxyl-gfp-racA´cat) amyE::Pxyl-divIVA
Lm-104-Bs spc divIVA::tet this work 
BSN344 168 racA::pSG4916(Pxyl-gfp-racA´cat) amyE::Pxyl-divIVA
Bs-57-Lm spc divIVA::tet this work 
BSN356 168 aprE::Pspac-divIVA
Bs cat lacI divIVA::tet this work 
BSN357 168 aprE::Pspac-divIVA
BsR102K cat lacI divIVA::tet this work 
BSN358 168 aprE::Pspac-divIVA
BsR102E cat lacI divIVA::tet this work 
BSN360 168 aprE::Pspac-divIVA
BsΔC34 cat lacI divIVA::tet this work 
BNS372 168 amyE::Pxyl- divIVA
Bs-57-Lm-gfpA206K spc divIVA::tet this work 
BSN373 168 amyE::Pxyl- divIVA




Table 2: Oligonucleotides used in this study. 1 
















































Table 3: Bacterial two-hybrid analysis of C-terminal DivIVA truncation mutants regarding 1 
their ability to interact with full-length DivIVA, MinJ, and RacA. 2 
DivIVA C-terminal protein sequence* DivIVA MinJ RacA 
wt LKKQSKVFRTRFQMLIEAQLDLLKNDDWDHLLEYEVDAVFEEKE-164 + + +/- 
∆11 LKKQSKVFRTRFQMLIEAQLDLLKNDDWDHLLE-153 + + - 
∆20 LKKQSKVFRTRFQMLIEAQLDLLK-144 + + - 
∆21 LKKQSKVFRTRFQMLIEAQLDLL-143 + + - 
∆26 LKKQSKVFRTRFQMLIEA-138 +/- +/- - 
∆34 LKKQSKVFRT-130 +/- +/- - 
* Starting from position 121. The shadowed sequence stretch corresponds to the DivIVA tetramerization 3 
domain. The position of the last amino acid in the truncated DivIVA proteins is given at the end of the sequence 4 
Symbols: + = dark blue, +/- = light blue, - = white. For comparison see Fig. S1. 5 
1 54 55 154 155 164





































van Baarle et al., Figure 2







             10        20        30        40        50        60 
              |         |         |         |         |      *  | 
Bs   MPLTPNDIHNKTFTKSFRGYDEDEVNEFLAQVRKDYEIVLRKKTELEAKVNELDERIGHF 
Lm   MPLSPLDIHNKEFTRGFRGYDEDEVNDFLDQIIKDYEQVIKEKKRIEDTLNNSEERLGHF 
 
             70        80        90       100       110       120 
              |*        |  *      |         |   *     |         | 
Bs   ANIEETLNKSILVAQEAAEDVKRNSQKEAKLIVREAEKNADRIINESLSKSRKIAMEIEE 
Lm   TNIEETLNKSLIVAQTAAEEVKASAEKEAKLIIREAEKNADRILSDSLSKARKIAIEIED 
 
            130       140       150       160       170 
              *         |   *     |         |         | 
Bs   LKKQSKVFRTRFQMLIEAQLDLLKNDDWDHLLEYEVDAVFEEKE----------- 











































van Baarle et al., Figure 5





































van Baarle et al., Figure 6
Fig. S1: Bacterial two hybrid analysis of the DivIVA interaction to MinJ and RacA. (A) The T25 plasmids p25-N-
divIVA (full length DivIVA), pSBLH004 (DivIVAΔ11), pSBLH008 (DivIVAΔ20), pSBLH039 (DivIVAΔ21),
pSBLH040 (DivIVAΔ26), and pSBLH041 (DivIVAΔ34), were co-transformed with the T18 plasmids pUT18C-
divIVA, pUT18C-racA, and pUT18C-minJ in the E. coli strain BTH101 and aliquots of the transformation mixture
were spotted onto nutrient agar plates containing ampicillin, kanamycin, IPTG and X-Gal (for details see
materials and methods section). Images were taken after 40 h of incubation at 30°C. The T25 plasmids pKT25-
racA and p25-N-minJ were used as self-interaction controls. (B) Reciprocal bacterial two hybrid experiment
(taken from the same plate) in which the T25 plasmids p25-N-divIVA, pKT25-racA, and p25-N-minJ were co-
transformed into BTH101 along with pUT18 plasmids containing the DivIVA truncation series. This experiment
confirmed the reduced interaction of DivIVAΔ26 and DivIVAΔ34 with full-length DivIVA. However, T25 fusions of

























Fig. S2: Western blot after blue native PAGE to analyze oligomerization of chimeric DivIVA proteins. Strains
expressing chimeric DivIVA proteins (BSN274: +Lm-144-Bs divIVA; BSN278: +Lm-130-Bs divIVA; BSN288:
+Lm-104-Bs divIVA; BSN287: +Lm-83-Bs divIVA; BSN316: +Lm-71-Bs divIVA; BSN321: +Bs-57-Lm divIVA)
were grown in LB broth supplemented with 0.5% xylose at 37°C and harvested in mid-logarithmic growth phase.
Cell extracts were subjected to blue native PAGE, blotted onto a PVDF membrane and DivIVA proteins were
immunostained using the anti-DivIVA antiserum. Strains 168 (wt), 4041 (ΔdivIVA) and strains expressing the B.
subtilis (BSN51) or the L. monocytogenes divIVA gene (BSN238) were used as controls. Please note that
differences in the apparent molecular weight of the different DivIVA oligomers are explained by pI differences
between Bs (pI 5.03) and Lm DivIVA (pI 4.77).During electrophoresis, which was performed at pH7.5, Lm DivIVA
is more negatively charged as compared to Bs DivIVA and therefore runs faster through the gel even though its
monomer has the higher theoretical molecular weight. Moreover, the pI values of the C-terminal domains of both
proteins are nearly identical (Bs CTD: 4.93; Lm CTD: 4.80) whereas those of the N-terminal lipid binding
domains are rather different (Bs LBD: 5.27; Lm LBD: 4.72). This explains why all chimeras containing the Lm
LBD reveal the same apparent oligomer molecular weight as Lm DivIVA, whereas the Bs-57-Lm oligomer runs at






















Fig. S3: A mutation in the tetramerisation domain (R131A) that causes an inactive Bs DivIVA protein. (A) Phase
contrast micrographs obtained on cultures that were cultivated in LB broth containing 1 mM IPTG at 37°C during
mid-logarithmic growth. Strains used were 168 (wt), 4041 (∆divIVA), BSN5 (+divIVA) and BSN313 (+R131A).
Scale bar is 5 µm. (B) Western blot on cell extracts of the same set of strains. DivIVA was visualised using the
polyclonal rabbit anti-DivIVA antiserum. (C) The divIVAR131A mutant (strain BSN313) reveals a sporulation
defect. Sporulation was assayed in a plate assay as described in the legend of Fig. 3B.
A
Fig. S4: Subcellular localisation of chimeric DivIVA proteins in a B. subtilis ∆divIVA background. Strains BSN294
(DivIVALm-71-Bs-GFP), BSN295 (DivIVALm-144-Bs-GFP), BSN296 (DivIVALm-130-Bs-GFP), BSN297 (DivIVALm-83-Bs-
GFP), BSN298 (DivIVALm-104-Bs-GFP), and strain BSN372 (DivIVABs-57-Lm-GFP) were grown in LB supplemented
with 0.5% xylose. DivIVA localisation patterns were analysed by epifluorescence microscopy (right images), and
for orientation, FM5-95 stained images (left panels) were taken in parallel. Scale bar is 5 µm, septal DivIVA-GFP
signals are indicated by arrows. All DivIVA-GFP fusions contain the gfpA206K mutation preventing GFP
dimerization. (B) Western blot to demonstrate full-length expression of chimeric DivIVA-GFP proteins. Strains
expressing chimeric DivIVA-GFP fusions were grown in LB broth containing or not containing 0.5% xylose to
mid-logarithmic growth phase, total cellular proteins were isolated and subjected to SDS-PAGE and subsequent
Western blotting. DivIVA-GFP fusion proteins were visualised using the polyclonal anti-GFP antiserum. Strains
were as in panel A, but BSN373 (expressing Lm DivIVA-GFP) was also included. For convenience the names of















Fig. S5: Mutations of R102 in Bs divIVA cause a div+ spo– phenotype. (A) Phase contrast micrographs obtained
on cultures that were cultivated in LB broth containing 1 mM IPTG (where necessary) at 37°C during mid-
logarithmic growth. Strains used for this experiment were 168 (wt), 4041 (∆divIVA), BSN356 (+divIVA), BSN357
(+R102K), and BSN358 (+R102E). Scale bar is 5 µm. (B) Western blot on cell extracts of the same set of strains.
DivIVA was visualised using the polyclonal rabbit anti-DivIVA antiserum. (C) Sporulation activity of the R102
mutants. Sporulation was assayed in a plate assay as described in the legend of Fig. 3. Please note that the
sporulation defect of the phospho-ablative R102K mutant was less pronounced than that of the phospho-mimetic
R102E allele.
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